Literature DB >> 8180123

Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor beta 1 in cycling epithelial cells.

S T Eblen1, M P Fautsch, R J Burnette, P Joshi, E B Leof.   

Abstract

Cycling epithelial cells were shown to reversibly arrest in late G1 phase following treatment with transforming growth factor beta 1. Associated with this G1-S phase arrest was a decrease in the synthesis and histone H1 kinase activity of p34cdc2. Transforming growth factor beta 1 did not reduce p34cdc2 levels by modulating the turnover of newly synthesized p34cdc2. The decrease in p34cdc2 synthesis preceded any detectable effect on DNA synthesis. Moreover, the action of transforming growth factor beta 1 was regulated in a cell cycle-specific manner; epithelial cells were sensitive to transforming growth factor beta 1 only during the G1 phase. The results suggest that p34cdc2 might be a useful biochemical marker for investigating the mechanism(s) of transforming growth factor beta 1 signaling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180123

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  4 in total

1.  A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells.

Authors:  Masako Miura; Xiao-Dong Chen; Matthew R Allen; Yanming Bi; Stan Gronthos; Byoung-Moo Seo; Saquib Lakhani; Richard A Flavell; Xin-Hua Feng; Pamela Gehron Robey; Marian Young; Songtao Shi
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells.

Authors:  A H Limper; M Edens; R A Anders; E B Leof
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 3.  Abrogation of transforming growth factor-beta signaling in pancreatic cancer.

Authors:  Xia Lin; Xin-Hua Feng
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

4.  Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells.

Authors:  Igor Bryukhovetskiy; Valeriy Shevchenko
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.